Search Results
Found 1271 results for ""
HPV-SS-Clinical-Pathway_Immunocompromised
attachment
HPV Self-Sampling Clinical Pathway HPVImSmeluf-nSoacmomplpinrogmCisliendicPaaltPieantthsway Immunocompromised Patients Immunocompromised* Patient Self Collected HPV Test HPV Negative HPV Positive High Risk Other Strain HPV Positive 16/18 Program Refers Program Refers Return to screening in 3 years * Patients with HIV, lymphoproliferative disorders, organ transplantation, long-term use of oral corticosteroids, or common/long-term use…
FIT Video
attachment
FIT Video
attachment
Screenshot_29-8-2025_15218_www.youtube.com
attachment
cervical-cancer-screening-summary
attachment
CERVICAL CANCER SCREENING Summary of the Clinical Practice Guideline | May 2016 These recommendations pertain to asymptomatic women. If the woman is symptomatic she should be investigated regardless of age. See: ‘Abnormal Uterine Bleeding in Pre-Menopausal Women’ at: https://sogc.org/clinical-practice-guidelines.html. Initiate Screening Cervical cancer screening applies to women including transgender people…
cervical-cancer-screening-guideline
attachment
CERVICAL CANCER SCREENING Clinical Practice Guideline | May 2016 OBJECTIVE Alberta clinicians will understand the recent evidence, offer age and risk-appropriate cervical cancer screening, and follow up on abnormal screen results. TARGET POPULATION Consider all women 21-69 years of age who are or have ever been sexually active. Include transgender…
Clinical Practice Guidelines - Cervical
resources
Screenshot_22-7-2025_121258_
attachment